查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933309

全球分子影像市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析、未来预测（2026-2034）

Molecular Imaging Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 请询问到货日

价格

分子影像市场成长因素

受慢性病盛行率上升和先进诊断技术广泛应用的推动，全球分子影像市场正经历稳定成长。2025年，该市场规模为23.2亿美元，预计2026年将达到24.5亿美元。在预测期内，到2034年，该市场预计将达到39.2亿美元，年复合成长率（CAGR）为6.05%。北美地区在2025年将以43.69%的市场占有率领跑，这主要得益于高昂的医疗保健支出以及先进影像系统的早期应用。

分子影像技术能够视觉化和测量细胞及分子层面的生物过程，在疾病的早期检测、诊断和治疗监测中发挥关键作用。正子断层扫描（PET）和单光子发射电脑断层扫描（SPECT）等技术已广泛应用于肿瘤学、神经病学、心臟病学和骨科等领域。

市场驱动因素

分子影像市场的主要驱动因素是慢性病和急性病患病率的不断上升，包括癌症、阿兹海默症、心血管疾病和神经系统疾病。根据美国国家癌症研究所预测，美国预计将新增约200万例癌症病例，这将显着增加对先进诊断影像技术的需求。

此外，人口老化加剧也促使诊断率上升。老年人更容易患慢性疾病，这推动了分子影像技术的应用。人们对疾病早期检测意识的提高以及影像精度的不断提升也进一步推动了市场成长。

市场限制与挑战

儘管市场稳定成长，但分子影像设备的高昂成本仍是市场面临的一大挑战。 PET/CT扫描仪的价格在50万美元到500万美元之间，这限制了其普及，尤其是在中低收入国家。

另一个主要挑战是翻新影像设备监管市场的出现。翻新PET/CT扫描仪的价格远低于新系统，在新兴经济体中越来越受欢迎。这种价格差异抑制了新设备的销售，并影响了製造商的收入成长。

市场机会与趋势

分子影像在医学领域的应用范围不断扩大，为其带来了强劲的成长机会。它正日益用于评估治疗效果、指导个人化医疗以及即时检测。更快的影像撷取流程和更高的影像品质进一步推动了其在临床环境中的应用。

市场的一个显着趋势是向技术先进的混合成像系统（例如PET/CT和SPECT/CT）的转变。这些系统具有更高的解析度、更短的扫描时间和更高的诊断准确性。监管机构的批准以及主要製造商的持续创新加速从传统成像技术向混合成像技术的过渡。

细分市场洞察

依类型划分，正子断层扫描（PET）占据了最大的市场占有率，这主要得益于神经系统疾病盛行率的上升以及每百万人口中PET扫描仪安装数量的增加。由于研发投入的增加，SPECT领域也预计将稳定成长。

依应用领域划分，肿瘤学领域因癌症诊断率的提高而成为市场成长的主要驱动力。由于损伤率和神经系统疾病的增加，骨科和神经系统疾病领域预计将以显着的年复合成长率成长。

依终端用户划分，诊断影像中心预计将快速成长，这得益于患者就医便利性的提高、等待时间的缩短以及独立影像诊断机构的兴起。

区域分析

到2025年，北美地区的市场收入达到10.1亿美元，主要得益于先进的医疗基础设施和有利的偿付政策。欧洲市场持续成长，这主要得益于诊断影像设备安装量的增加以及政府支持的研究计画。亚太地区预计将成为成长最快的地区，这主要得益于庞大的患者群体、人口老化以及中国、日本和印度等国家不断扩大的医疗基础设施。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 主要国家/地区主要疾病盛行率（2024/2025）
  • 分子影像设备的技术进步
  • 主要国家安装量（2024/2025）
  • 主要公司新产品发布
  • 关键趋势：併购併购与业务合作
  • 新冠疫情对市场的影响

第5章 全球分子影像市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依类型划分
    • 正子断层扫描（PET）
    • 单光子发射电脑断层扫描（SPECT）
    • 其他
  • 市场分析、洞察与预测：依应用划分
    • 心臟疾病
    • 肿瘤
    • 骨科
    • 妇科
    • 神经系统疾病
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 医院
    • 专科诊所
    • 诊断影像中心
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美分子影像市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲分子影像市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第8章 亚太分子影像市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 澳洲
    • 中国
    • 印度
    • 东南亚
    • 亚太其他地区

第9章 拉丁美洲分子影像市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区美国

第10章 中东与非洲分子影像市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • GCC国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司简介
    • GE Healthcare
    • Siemens Healthineers AG
    • Koninklijke Philips N.V.
    • Shimadzu Corporation
    • CANON MEDICAL SYSTEMS CORPORATION
    • Bruker
    • Lantheus Holdings, Inc.
    • Segami Corporation
Product Code: FBI112879

Growth Factors of molecular imaging Market

The global molecular imaging market is witnessing consistent growth driven by rising prevalence of chronic diseases and increasing adoption of advanced diagnostic technologies. In 2025, the market was valued at USD 2.32 billion and is projected to grow to USD 2.45 billion in 2026. Over the forecast period, the market is expected to reach USD 3.92 billion by 2034, expanding at a CAGR of 6.05%. North America dominated the market with a 43.69% share in 2025, supported by high healthcare expenditure and early adoption of advanced imaging systems.

Molecular imaging enables visualization and measurement of biological processes at the cellular and molecular levels, playing a crucial role in early disease detection, diagnosis, and treatment monitoring. Technologies such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) are widely used across oncology, neurology, cardiology, and orthopedics.

Market Drivers

The primary driver of the molecular imaging market is the increasing prevalence of chronic and acute disorders, including cancer, Alzheimer's disease, cardiovascular diseases, and neurological conditions. According to the National Cancer Institute, nearly 2.0 million new cancer cases were expected to be diagnosed in the U.S., significantly increasing demand for advanced diagnostic imaging.

Additionally, the growing geriatric population is contributing to higher diagnosis rates. Aging populations are more susceptible to chronic conditions, thereby boosting the utilization of molecular imaging techniques. Rising awareness about early disease detection and continuous improvements in imaging accuracy further support market growth.

Market Restraints and Challenges

Despite steady growth, the market faces challenges due to the high cost of molecular imaging equipment. PET/CT scanners can cost between USD 0.5 million and USD 5.0 million, limiting adoption, particularly in low- and middle-income countries.

Another major challenge is the emergence of a regulated market for refurbished imaging devices. Refurbished PET/CT scanners, priced significantly lower than new systems, are gaining traction in emerging economies. This price gap is restraining new equipment sales and impacting revenue growth for manufacturers.

Market Opportunities and Trends

The expanding range of medical applications for molecular imaging presents strong growth opportunities. Molecular imaging is increasingly used to assess treatment response, guide personalized medicine, and enable point-of-care testing. Faster imaging procedures and improved image quality have further enhanced clinical adoption.

A prominent trend in the market is the shift toward technologically advanced hybrid imaging systems, such as PET/CT and SPECT/CT. These systems offer superior resolution, reduced scan times, and enhanced diagnostic accuracy. Regulatory approvals and continuous innovation by leading manufacturers are accelerating the transition from conventional to hybrid imaging technologies.

Segmentation Insights

By type, Positron Emission Tomography (PET) held the largest market share, driven by rising neurological disorder prevalence and increasing installed scanner bases per million population. The SPECT segment is also expected to grow steadily due to rising R&D investments.

By application, oncology dominated the market, owing to increasing cancer diagnosis rates. Orthopedics and neurology are anticipated to grow at notable CAGRs due to rising injury rates and neurological disorders.

By end-user, diagnostic imaging centers are expected to grow rapidly, supported by patient convenience, reduced waiting times, and the growing number of independent imaging facilities.

Regional Analysis

North America generated USD 1.01 billion in revenue in 2025, driven by advanced healthcare infrastructure and favorable reimbursement policies. Europe continues to grow due to increasing installed imaging bases and government-backed research initiatives. Asia Pacific is projected to be the fastest-growing region, supported by a large patient pool, aging population, and expanding healthcare infrastructure in countries such as China, Japan, and India.

Competitive Landscape

The molecular imaging market is consolidated, with key players such as GE Healthcare, Siemens Healthineers AG, and Koninklijke Philips N.V. dominating global market share. These companies focus on innovation, product launches, and strategic collaborations to strengthen their market presence.

Conclusion

The global molecular imaging market is poised for steady growth, expanding from USD 2.32 billion in 2025 to USD 3.92 billion by 2034. Rising prevalence of chronic diseases, increasing adoption of hybrid imaging technologies, and advancements in personalized medicine are key growth drivers. While high equipment costs and refurbished device markets pose challenges, continuous innovation and expanding clinical applications will ensure sustained market expansion throughout the forecast period.

Segmentation By Type

  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Others

By Application

  • Cardiology
  • Oncology
  • Orthopedics
  • Gynecology
  • Neurology
  • Others

By End-user

  • Hospitals
  • Specialty Clinics
  • Diagnostic Imaging Centers
  • Others

By Geography

  • North America (By Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2024/2025
  • 4.2. Technological Advancements in Molecular Imaging Equipment
  • 4.3. Installed Base, Key Countries/Regions, 2024/2025
  • 4.4. New Product Launches, Key Players
  • 4.5. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.6. Impact of COVID-19 on the Market

5. Global Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Positron Emission Tomography (PET)
    • 5.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Cardiology
    • 5.2.2. Oncology
    • 5.2.3. Orthopedics
    • 5.2.4. Gynecology
    • 5.2.5. Neurology
    • 5.2.6. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Diagnostic Imaging Centers
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Positron Emission Tomography (PET)
    • 6.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Cardiology
    • 6.2.2. Oncology
    • 6.2.3. Orthopedics
    • 6.2.4. Gynecology
    • 6.2.5. Neurology
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Diagnostic Imaging Centers
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Positron Emission Tomography (PET)
    • 7.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Cardiology
    • 7.2.2. Oncology
    • 7.2.3. Orthopedics
    • 7.2.4. Gynecology
    • 7.2.5. Neurology
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Diagnostic Imaging Centers
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia pacific Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Positron Emission Tomography (PET)
    • 8.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Cardiology
    • 8.2.2. Oncology
    • 8.2.3. Orthopedics
    • 8.2.4. Gynecology
    • 8.2.5. Neurology
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Diagnostic Imaging Centers
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Positron Emission Tomography (PET)
    • 9.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Cardiology
    • 9.2.2. Oncology
    • 9.2.3. Orthopedics
    • 9.2.4. Gynecology
    • 9.2.5. Neurology
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Diagnostic Imaging Centers
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Positron Emission Tomography (PET)
    • 10.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Cardiology
    • 10.2.2. Oncology
    • 10.2.3. Orthopedics
    • 10.2.4. Gynecology
    • 10.2.5. Neurology
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Diagnostic Imaging Centers
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. GE Healthcare
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Siemens Healthineers AG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Koninklijke Philips N.V.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Shimadzu Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. CANON MEDICAL SYSTEMS CORPORATION
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Bruker
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Lantheus Holdings, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Segami Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 4: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 6: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 8: North America Molecular Imaging Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 10: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: Europe Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 16: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 18: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 20: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 24: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Molecular Imaging Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Molecular Imaging Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Molecular Imaging Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Molecular Imaging Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Molecular Imaging Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 8: North America Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 10: North America Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 12: North America Molecular Imaging Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Molecular Imaging Market Value Share (%), By Country, 2025
  • Figure 14: Europe Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 16: Europe Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 18: Europe Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 20: Europe Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Molecular Imaging Market Share (%), By Company, 2025